Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Contract Liability and Receivable - Narrative (Details)

v3.8.0.1
Contract Liability and Receivable - Narrative (Details)
$ in Millions
1 Months Ended
Nov. 30, 2017
USD ($)
patient
Dec. 31, 2017
CAD ($)
Dec. 31, 2016
CAD ($)
Class of Warrant or Right1 [Line Items]      
Warrant purchase agreement $ 8    
Expected recognition period 5    
Contract receivable   $ 4,767,100 $ 0
Milestone 1      
Class of Warrant or Right1 [Line Items]      
Warrant purchase agreement $ 2    
Common share premium 20.00%    
Weighted average closing price term 5    
Patients | patient 1    
Right to call warrant from time of agreement, term 6    
Milestone 2      
Class of Warrant or Right1 [Line Items]      
Warrant purchase agreement $ 6    
Common share premium 20.00%    
Weighted average closing price term 5    
Patients | patient 50